Cargando…
Saliva cotinine concentrations in pregnant women who smoke and use nicotine patches
BACKGROUND AND AIMS: Due to concerns about increased exposure to nicotine, pregnant women using nicotine replacement therapy (NRT) to stop smoking are usually advised to stop using NRT if they relapse to smoking. This study investigated whether this is justified. We compared changes in saliva cotini...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771792/ https://www.ncbi.nlm.nih.gov/pubmed/31106486 http://dx.doi.org/10.1111/add.14662 |
_version_ | 1783455768237834240 |
---|---|
author | Claire, Ravinder Coleman, Tim Leonardi‐Bee, Jo Berlin, Ivan |
author_facet | Claire, Ravinder Coleman, Tim Leonardi‐Bee, Jo Berlin, Ivan |
author_sort | Claire, Ravinder |
collection | PubMed |
description | BACKGROUND AND AIMS: Due to concerns about increased exposure to nicotine, pregnant women using nicotine replacement therapy (NRT) to stop smoking are usually advised to stop using NRT if they relapse to smoking. This study investigated whether this is justified. We compared changes in saliva cotinine from baseline to 2 weeks post‐target quit date pregnant smokers who relapsed to smoking and continued to use their patches having been assigned to use nicotine patches or placebo. DESIGN AND SETTING: Controlled pre–post design stratified by intervention condition from the ‘Study of Nicotine Patch in Pregnancy’, a randomized, placebo‐controlled trial. PARTICIPANTS: A sample of 268 pregnant women, assigned placebo (n = 122) or nicotine (n = 146) patches, who returned for further supplies of patches and who reported any smoking in the week prior to a visit at 2 weeks after their target quit date. MEASUREMENTS: Saliva cotinine concentrations were measured at baseline and 2 weeks after participants’ target quit dates. Any smoking in the previous week was assessed by self‐report, validated by expired air carbon monoxide (CO). FINDINGS: There was no change in saliva cotinine concentrations between baseline and 2 weeks post‐target quit date in saliva cotinine concentration in the nicotine patch group [ratio of geometric means = 0.94, 95% confidence interval (CI) = 0.83 to 1.07; P = 0.37, Bayes factor = 0.15]. However, there was a reduction in reported number of cigarettes smoked/day (mean difference −6, 95% CIs −7 to −5, P < 0.001) and in CO concentrations (mean difference −3.0 parts per million, 95% CIs −4.2 to −1.9, P < 0.001). These changes were not significantly different from changes in the placebo group except for cigarette consumption, which reduced more in the nicotine group (P = 0.046). CONCLUSIONS: In women trying to stop smoking with the aid of a nicotine patch but having smoked at 2 weeks post‐target quit, their nicotine concentration did not change from baseline, but they reported smoking fewer cigarettes and had lower carbon monoxide concentrations. |
format | Online Article Text |
id | pubmed-6771792 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-67717922019-10-07 Saliva cotinine concentrations in pregnant women who smoke and use nicotine patches Claire, Ravinder Coleman, Tim Leonardi‐Bee, Jo Berlin, Ivan Addiction Research Reports BACKGROUND AND AIMS: Due to concerns about increased exposure to nicotine, pregnant women using nicotine replacement therapy (NRT) to stop smoking are usually advised to stop using NRT if they relapse to smoking. This study investigated whether this is justified. We compared changes in saliva cotinine from baseline to 2 weeks post‐target quit date pregnant smokers who relapsed to smoking and continued to use their patches having been assigned to use nicotine patches or placebo. DESIGN AND SETTING: Controlled pre–post design stratified by intervention condition from the ‘Study of Nicotine Patch in Pregnancy’, a randomized, placebo‐controlled trial. PARTICIPANTS: A sample of 268 pregnant women, assigned placebo (n = 122) or nicotine (n = 146) patches, who returned for further supplies of patches and who reported any smoking in the week prior to a visit at 2 weeks after their target quit date. MEASUREMENTS: Saliva cotinine concentrations were measured at baseline and 2 weeks after participants’ target quit dates. Any smoking in the previous week was assessed by self‐report, validated by expired air carbon monoxide (CO). FINDINGS: There was no change in saliva cotinine concentrations between baseline and 2 weeks post‐target quit date in saliva cotinine concentration in the nicotine patch group [ratio of geometric means = 0.94, 95% confidence interval (CI) = 0.83 to 1.07; P = 0.37, Bayes factor = 0.15]. However, there was a reduction in reported number of cigarettes smoked/day (mean difference −6, 95% CIs −7 to −5, P < 0.001) and in CO concentrations (mean difference −3.0 parts per million, 95% CIs −4.2 to −1.9, P < 0.001). These changes were not significantly different from changes in the placebo group except for cigarette consumption, which reduced more in the nicotine group (P = 0.046). CONCLUSIONS: In women trying to stop smoking with the aid of a nicotine patch but having smoked at 2 weeks post‐target quit, their nicotine concentration did not change from baseline, but they reported smoking fewer cigarettes and had lower carbon monoxide concentrations. John Wiley and Sons Inc. 2019-06-30 2019-09 /pmc/articles/PMC6771792/ /pubmed/31106486 http://dx.doi.org/10.1111/add.14662 Text en © 2019 The Authors. Addiction published by John Wiley & Sons Ltd on behalf of Society for the Study of Addiction This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Reports Claire, Ravinder Coleman, Tim Leonardi‐Bee, Jo Berlin, Ivan Saliva cotinine concentrations in pregnant women who smoke and use nicotine patches |
title | Saliva cotinine concentrations in pregnant women who smoke and use nicotine patches |
title_full | Saliva cotinine concentrations in pregnant women who smoke and use nicotine patches |
title_fullStr | Saliva cotinine concentrations in pregnant women who smoke and use nicotine patches |
title_full_unstemmed | Saliva cotinine concentrations in pregnant women who smoke and use nicotine patches |
title_short | Saliva cotinine concentrations in pregnant women who smoke and use nicotine patches |
title_sort | saliva cotinine concentrations in pregnant women who smoke and use nicotine patches |
topic | Research Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771792/ https://www.ncbi.nlm.nih.gov/pubmed/31106486 http://dx.doi.org/10.1111/add.14662 |
work_keys_str_mv | AT claireravinder salivacotinineconcentrationsinpregnantwomenwhosmokeandusenicotinepatches AT colemantim salivacotinineconcentrationsinpregnantwomenwhosmokeandusenicotinepatches AT leonardibeejo salivacotinineconcentrationsinpregnantwomenwhosmokeandusenicotinepatches AT berlinivan salivacotinineconcentrationsinpregnantwomenwhosmokeandusenicotinepatches |